rVSV vector vaccine primed with GeneVax (Profectus)

N/A

Report date: 2025/01/26 17:04:02

Base Information

Drug NamerVSV vector vaccine primed with GeneVax (Profectus)

Drug Alias Namerecombinant vesicular stomatitis virus vector vaccine (Profectus)recombinant vesicular stomatitis virus vector vaccine (Auro vaccines)rVSV vector vaccine (Profectus)

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsPapillomavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesAuro Vaccines Llc

Inactive Companies +[1] N/A

Active IndicationsPapillomavirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A